HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 614 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,825,704 | -73.1% | 15,781 | -76.1% | 0.01% | -72.2% |
| Q2 2023 | $6,794,913 | +79400.6% | 66,066 | -15.6% | 0.02% | -28.0% |
| Q1 2023 | $8,547 | -5.3% | 78,306 | -1.3% | 0.02% | -13.8% |
| Q4 2022 | $9,029 | -99.8% | 79,339 | -13.4% | 0.03% | +26.1% |
| Q3 2022 | $5,667,000 | -19.6% | 91,572 | +3.7% | 0.02% | -20.7% |
| Q2 2022 | $7,046,000 | -29.4% | 88,332 | -6.9% | 0.03% | -23.7% |
| Q1 2022 | $9,987,000 | -5.0% | 94,924 | -2.7% | 0.04% | -13.6% |
| Q4 2021 | $10,515,000 | -0.1% | 97,579 | +1.6% | 0.04% | -20.0% |
| Q3 2021 | $10,522,000 | +40.9% | 96,057 | +20.4% | 0.06% | +19.6% |
| Q2 2021 | $7,468,000 | +2.0% | 79,752 | +0.3% | 0.05% | -9.8% |
| Q1 2021 | $7,318,000 | +378.3% | 79,519 | +280.3% | 0.05% | +325.0% |
| Q4 2020 | $1,530,000 | – | 20,911 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |